Many studies have demonstrated a relationship between high blood pressure and albuminuria [54] and the beneficial renoprotective effects of angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers on the progression of CKD in patients with hypertension and diabetes [55-59]. This evidence concerns the gene ACE and hypertensive disorder.